191 related articles for article (PubMed ID: 36424895)
1. Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling.
Bitting K; Hedgespeth B; Ehrhardt-Humbert LC; Arthur GK; Schubert AG; Bradding P; Tilley SL; Cruse G
Allergy; 2023 May; 78(5):1204-1217. PubMed ID: 36424895
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation.
Arthur GK; Cruse G
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054974
[TBL] [Abstract][Full Text] [Related]
3. The FcεRIβ homologue, MS4A4A, promotes FcεRI signal transduction and store-operated Ca
Arthur GK; Ehrhardt-Humbert LC; Snider DB; Jania C; Tilley SL; Metcalfe DD; Cruse G
Cell Signal; 2020 Jul; 71():109617. PubMed ID: 32240745
[TBL] [Abstract][Full Text] [Related]
4. The interaction between Lyn and FcεRIβ is indispensable for FcεRI-mediated human mast cell activation.
Okayama Y; Kashiwakura JI; Matsuda A; Sasaki-Sakamoto T; Nunomura S; Yokoi N; Ebihara N; Kuroda K; Ohmori K; Saito H; Ra C
Allergy; 2012 Oct; 67(10):1241-9. PubMed ID: 22845063
[TBL] [Abstract][Full Text] [Related]
5. Exon Skipping of FcεRIβ for Allergic Diseases.
Arthur GK; Cruse G
Methods Mol Biol; 2018; 1828():503-518. PubMed ID: 30171564
[TBL] [Abstract][Full Text] [Related]
6. Highly expressed cytoplasmic FcεRIβ in human mast cells functions as a negative regulator of the FcRγ-mediated cell activation signal.
Okayama Y; Matsuda A; Kashiwakura JI; Sasaki-Sakamoto T; Nunomura S; Shimokawa T; Yamaguchi K; Takahashi S; Ra C
Clin Exp Allergy; 2014 Feb; 44(2):238-49. PubMed ID: 24118172
[TBL] [Abstract][Full Text] [Related]
7. Exon skipping of FcεRIβ eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergy.
Cruse G; Yin Y; Fukuyama T; Desai A; Arthur GK; Bäumer W; Beaven MA; Metcalfe DD
Proc Natl Acad Sci U S A; 2016 Dec; 113(49):14115-14120. PubMed ID: 27872312
[TBL] [Abstract][Full Text] [Related]
8. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response.
Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ
Front Immunol; 2019; 10():1020. PubMed ID: 31156621
[TBL] [Abstract][Full Text] [Related]
9. The role of the FcepsilonRI beta-chain in allergic diseases.
Kraft S; Rana S; Jouvin MH; Kinet JP
Int Arch Allergy Immunol; 2004 Sep; 135(1):62-72. PubMed ID: 15316148
[TBL] [Abstract][Full Text] [Related]
10. A truncated splice-variant of the FcεRIβ receptor subunit is critical for microtubule formation and degranulation in mast cells.
Cruse G; Beaven MA; Ashmole I; Bradding P; Gilfillan AM; Metcalfe DD
Immunity; 2013 May; 38(5):906-17. PubMed ID: 23643722
[TBL] [Abstract][Full Text] [Related]
11. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.
Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C
J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354
[TBL] [Abstract][Full Text] [Related]
12. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
13. Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils.
Saini SS; Richardson JJ; Wofsy C; Lavens-Phillips S; Bochner BS; Macglashan DW
J Allergy Clin Immunol; 2001 May; 107(5):832-41. PubMed ID: 11344350
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response.
Lin KC; Huang DY; Huang DW; Tzeng SJ; Lin WW
J Mol Med (Berl); 2016 Feb; 94(2):183-94. PubMed ID: 26373430
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy.
Nishiyama C; Akizawa Y; Nishiyama M; Tokura T; Kawada H; Mitsuishi K; Hasegawa M; Ito T; Nakano N; Okamoto A; Takagi A; Yagita H; Okumura K; Ogawa H
J Immunol; 2004 Nov; 173(10):6458-64. PubMed ID: 15528387
[TBL] [Abstract][Full Text] [Related]
16. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.
Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM
J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573
[TBL] [Abstract][Full Text] [Related]
17. Recent Knowledge and Insights on the Mechanisms of Immediate Hypersensitivity and Anaphylaxis: IgE/FcεRI- and Non-IgE/FcεRI-Dependent Anaphylaxis.
Ebo DG; Beyens M; Heremans K; van der Poorten MM; Van Gasse AL; Mertens C; Houdt MV; Sabato V; Elst J
Curr Pharm Des; 2023; 29(3):178-184. PubMed ID: 36284380
[TBL] [Abstract][Full Text] [Related]
18. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
[TBL] [Abstract][Full Text] [Related]
19. FcεRI-induced mast cell cytokine production critically involves an aspartic acid residue (D234) in the C-terminal intracellular domain of the FcεRIβ chain.
Terada T; Nunomura S; Shimokawa T; Murayama K; Era S; Kondo N; Ra C
Biochem Biophys Res Commun; 2011 Jul; 410(4):744-8. PubMed ID: 21683687
[TBL] [Abstract][Full Text] [Related]
20. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
